13 results on '"Meisel, Marlies"'
Search Results
2. Team victory, yellow helmets for a computational tour de force.
- Author
-
Phelps, Catherine M. and Meisel, Marlies
- Subjects
- *
HELMETS , *GUT microbiome , *MULTIPLE sclerosis , *TEAMS - Abstract
Changes in the gut microbiota are associated with the etiopathogenesis of complex diseases, such as multiple sclerosis. In this issue of Cell , the international Multiple Sclerosis Microbiome Study consortium deployed a multi-omics approach to profile the composition and function of the gut microbiome in an extensive cohort of MS patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. The Kinase PKCα Selectively Upregulates Interleukin-17A during Th17 Cell Immune Responses
- Author
-
Meisel, Marlies, Hermann-Kleiter, Natascha, Hinterleitner, Reinhard, Gruber, Thomas, Wachowicz, Katarzyna, Pfeifhofer-Obermair, Christa, Fresser, Friedrich, Leitges, Michael, Soldani, Cristiana, Viola, Antonella, Kaminski, Sandra, and Baier, Gottfried
- Subjects
- *
PROTEIN kinase C , *INTERLEUKIN-17 , *T helper cells , *CELLULAR immunity , *IMMUNE response , *TRANSFORMING growth factors-beta , *CELLULAR signal transduction - Abstract
Summary: Transforming growth-factor β (TGFβ) has been implicated in T helper 17 (Th17) cell biology and in triggering expression of interleukin-17A (IL-17A), which is a key Th17 cell cytokine. Deregulated TGFβ receptor (TGFβR) signaling has been implicated in Th17-cell-mediated autoimmune pathogenesis. Nevertheless, the full molecular mechanisms involved in the activation of the TGFβR pathway in driving IL-17A expression remain unknown. Here, we identified protein kinase C α (PKCα) as a signaling intermediate specific to the Th17 cell subset in the activation of TGFβRI. We have shown that PKCα physically interacts and functionally cooperates with TGFβRI to promote robust SMAD2-3 activation. Furthermore, PKCα-deficient (Prkca −/− ) cells demonstrated a defect in SMAD-dependent IL-2 suppression, as well as decreased STAT3 DNA binding within the Il17a promoter. Consistently, Prkca −/− cells failed to mount appropriate IL-17A, but not IL-17F, responses in vitro and were resistant to induction of Th17-cell-dependent experimental autoimmune encephalomyelitis in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
4. Nuclear orphan receptor NR2F6 directly antagonizes NFAT and RORγt binding to the Il17a promoter
- Author
-
Hermann-Kleiter, Natascha, Meisel, Marlies, Fresser, Friedrich, Thuille, Nikolaus, Müller, Mathias, Roth, Lukas, Katopodis, Andreas, and Baier, Gottfried
- Subjects
- *
NFAT5 protein , *INTERLEUKINS , *CYTOKINES , *DNA , *HEREDITY , *PROTEIN binding , *PROMOTERS (Genetics) - Abstract
Abstract: Interleukin-17A (IL-17A) is the signature cytokine produced by Th17 CD4+ T cells and has been tightly linked to autoimmune pathogenesis. In particular, the transcription factors NFAT and RORγt are known to activate Il17a transcription, although the detailed mechanism of action remains incompletely understood. Here, we show that the nuclear orphan receptor NR2F6 can attenuate the capacity of NFAT to bind to critical regions of the Il17a gene promoter. In addition, because NR2F6 binds to defined hormone response elements (HREs) within the Il17a locus, it interferes with the ability of RORγt to access the DNA. Consistently, NFAT and RORγt binding within the Il17a locus were enhanced in Nr2f6-deficient CD4+ Th17 cells but decreased in Nr2f6-overexpressing transgenic CD4+ Th17 cells. Taken together, our findings uncover an example of antagonistic regulation of Il17a transcription through the direct reciprocal actions of NR2F6 versus NFAT and RORγt. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
5. Melanoma and microbiota: Current understanding and future directions.
- Author
-
Routy, Bertrand, Jackson, Tanisha, Mählmann, Laura, Baumgartner, Christina K., Blaser, Martin, Byrd, Allyson, Corvaia, Nathalie, Couts, Kasey, Davar, Diwakar, Derosa, Lisa, Hang, Howard C., Hospers, Geke, Isaksen, Morten, Kroemer, Guido, Malard, Florent, McCoy, Kathy D., Meisel, Marlies, Pal, Sumanta, Ronai, Ze'ev, and Segal, Eran
- Subjects
- *
IMMUNE checkpoint inhibitors , *GUT microbiome , *CANCER prognosis , *MELANOMA - Abstract
Over the last decade, the composition of the gut microbiota has been found to correlate with the outcomes of cancer patients treated with immunotherapy. Accumulating evidence points to the various mechanisms by which intestinal bacteria act on distal tumors and how to harness this complex ecosystem to circumvent primary resistance to immune checkpoint inhibitors. Here, we review the state of the microbiota field in the context of melanoma, the recent breakthroughs in defining microbial modes of action, and how to modulate the microbiota to enhance response to cancer immunotherapy. The host-microbe interaction may be deciphered by the use of "omics" technologies, and will guide patient stratification and the development of microbiota-centered interventions. Efforts needed to advance the field and current gaps of knowledge are also discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Altered hepatic and intestinal homeostasis in a neonatal murine model of shortterm total parenteral nutrition and antibiotics.
- Author
-
Mims, Tahliyah S., Kumari, Roshan, Leathem, Cameron, Antunes, Karen, Joseph, Sydney, Mei-I Yen, Ferstl, Danielle, Jamieson, Sophia M., Sabbar, Austin, Biebel, Claudia, Lazarevic, Nikolai, Willis, Nathaniel B., Henry, Lydia, Chi-Liang E. Yen, Smith, Joseph P., Gosain, Ankush, Meisel, Marlies, Willis, Kent A., Talati, Ajay J., and Elabiad, Mohammad. T.
- Subjects
- *
PARENTERAL feeding , *REGULATOR genes , *INFANT weaning , *ANTIBIOTICS , *INTESTINES , *COLONY-forming units assay , *LIVER histology - Abstract
Parenteral nutrition (PN) prevents starvation and supports metabolic requirements intravenously when patients are unable to be fed enterally. Clinically, infants are frequently provided PN in intensive care settings along with exposure to antibiotics (ABX) to minimize infection during care. Unfortunately, neonates experience extremely high rates of hepatic complications. Adult rodent and piglet models of PN are well-established but neonatal models capable of leveraging the considerable transgenic potential of the mouse remain underdeveloped. Utilizing our newly established neonatal murine PN mouse model, we administered ABX or controlled drinking water to timed pregnant dams to disrupt the maternal microbiome. We randomized mouse pups to PN or sham surgery controls +/- ABX exposure. ABX or short-term PN decreased liver and brain organ weights, intestinal length, and mucosal architecture (vs. controls). PN significantly elevated evidence of hepatic proinflammatory markers, neutrophils and macrophage counts, bacterial colony-forming units, and evidence of cholestasis risk, which was blocked by ABX. However, ABX uniquely elevated metabolic regulatory genes resulting in accumulation of hepatocyte lipids, triglycerides, and elevated tauro-chenoxycholic acid (TCDCA) in serum. Within the gut, PN elevated the relative abundance of Akkermansia, Enterococcus, and Suterella with decreased Anaerostipes and Lactobacillus compared with controls, whereas ABX enriched Proteobacteria. We conclude that short-term PN elevates hepatic inflammatory stress and risk of cholestasis in early life. Although concurrent ABX exposure protects against hepatic immune activation during PN, the dual exposure modulates metabolism and may contribute toward early steatosis phenotype, sometimes observed in infants unable to wean from PN. NEW & NOTEWORTHY This study successfully established a translationally relevant, murine neonatal parenteral nutrition (PN) model. Short-term PN is sufficient to induce hepatitis-associated cholestasis in a neonatal murine model that can be used to understand disease in early life. The administration of antibiotics during PN protects animals from bacterial translocation and proinflammatory responses but induces unique metabolic shifts that may predispose the liver toward early steatosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Protein Kinase C θ Regulates the Phenotype of Murine CD4+ Th17 Cells.
- Author
-
Wachowicz, Katarzyna, Hermann-Kleiter, Natascha, Meisel, Marlies, Siegmund, Kerstin, Thuille, Nikolaus, and Baier, Gottfried
- Subjects
- *
INFLAMMATION , *PROTEIN kinase C , *PHENOTYPES , *LABORATORY mice , *CELLULAR signal transduction , *T cell receptors , *ANTIGEN receptors - Abstract
Protein kinase C θ (PKCθ) is involved in signaling downstream of the T cell antigen receptor (TCR) and is important for shaping effector T cell functions and inflammatory disease development. Acquisition of Th1-like effector features by Th17 cells has been linked to increased pathogenic potential. However, the molecular mechanisms underlying Th17/Th1 phenotypic instability remain largely unknown. In the current study, we address the role of PKCθ in differentiation and function of Th17 cells by using genetic knock-out mice. Implementing in vitro (polarizing T cell cultures) and in vivo (experimental autoimmune encephalomyelitis model, EAE) techniques, we demonstrated that PKCθ-deficient CD4+ T cells show normal Th17 marker gene expression (interleukin 17A/F, RORγt), accompanied by enhanced production of the Th1-typical markers such as interferon gamma (IFN-γ) and transcription factor T-bet. Mechanistically, this phenotype was linked to aberrantly elevated Stat4 mRNA levels in PKCθ−/− CD4+ T cells during the priming phase of Th17 differentiation. In contrast, transcription of the Stat4 gene was suppressed in Th17-primed wild-type cells. This change in cellular effector phenotype was reflected in vivo by prolonged neurological impairment of PKCθ-deficient mice during the course of EAE. Taken together, our data provide genetic evidence that PKCθ is critical for stabilizing Th17 cell phenotype by selective suppression of the STAT4/IFN-γ/T-bet axis at the onset of differentiation. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
8. Coronin 1A is an essential regulator of the TGFβ receptor/SMAD3 signaling pathway in Th17 CD4+ T cells
- Author
-
Kaminski, Sandra, Hermann-Kleiter, Natascha, Meisel, Marlies, Thuille, Nikolaus, Cronin, Shane, Hara, Hiromitsu, Fresser, Friedrich, Penninger, Josef M., and Baier, Gottfried
- Subjects
- *
TRANSFORMING growth factors , *CELL communication , *T cells , *IMMUNE response , *SPINAL cord , *IMMUNOMODULATORS , *AUTOIMMUNITY - Abstract
Abstract: Transforming growth factor β (TGFβ) plays a central role in maintaining immune homeostasis by regulating the initiation and termination of immune responses and thus preventing the development of autoimmune diseases. In this study, we describe an essential mechanism by which the actin regulatory protein Coronin 1A (Coro1A) ensures the proper response of Th17 CD4+ T cells to TGFβ. Coro1A has been established as a key player in T cell survival, migration, activation, and Ca2+ regulation in naive T cells. We show that mice lacking Coro1a developed less severe experimental autoimmune encephalomyelitis (EAE). Unexpectedly, upon the re-induction of EAE, Coro1a −/− mice exhibited enhanced EAE signs that correlated with increased numbers of IL-17 producing CD4+ cells in the central nervous system (CNS) compared to wild-type mice. In vitro differentiated Coro1a −/− Th17 CD4+ T cells consistently produced more IL-17 than wild-type cells and displayed a Th17/Th1-like phenotype in regard to the expression of the Th1 markers T-bet and IFNγ. Mechanistically, the Coro1a −/− Th17 cell phenotype correlated with a severe defect in TGFβR-mediated SMAD3 activation. Taken together, these data provide experimental evidence of a non-redundant role of Coro1A in the regulation of Th17 CD4+ cell effector functions and, subsequently, in the development of autoimmunity. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
9. Systemic Immunoregulatory Consequences of Gut Commensal Translocation.
- Author
-
McPherson, Alex C., Pandey, Surya P., Bender, Mackenzie J., and Meisel, Marlies
- Subjects
- *
PROGNOSIS , *GUT microbiome , *MICROBIAL cells , *IMMUNE response , *AUTOIMMUNE diseases - Abstract
One major determinant of systemic immunity during homeostasis and in certain complex multifactorial diseases (e.g. cancer and autoimmune conditions), is the gut microbiota. These commensals can shape systemic immune responses via translocation of metabolites, microbial cell wall components, and viable microbes. In the last few years, bacterial translocation has revealed itself as playing a key, and potentially causal role in mediating immunomodulatory processes in nongastrointestinal diseases. Moreover, recent observations regarding the presence of complex microbial communities and viable bacteria within gut-distal tissues during homeostasis challenge the current paradigm that healthy mammals are entirely sterile at nonmucosal sites. This review discusses our current understanding of how the gut microbiota orchestrates systemic immunity during noninfectious extraintestinal diseases and homeostasis, focusing on the translocation of viable bacteria to gut-distal sites. A complex tissue microbiome, containing viable bacteria, is present at gut distal sites during homeostasis. A crucial, and potentially causal role of gut bacterial translocation in modulating systemic immunity during extraintestinal diseases, such as autoimmunity and cancer, is emerging. The systemic immunoregulatory consequences of gut bacterial translocation are contextual. Gut-distal tumors and circulatory systems of cancer patients can harbor cancer-type-specific microbial communities of prognostic value. The efficacy of cancer immunotherapy can be strongly associated with gut bacterial translocation. Bacterial translocation can exacerbate the severity of certain autoimmune diseases, potentially through modulating self-reactivity. The aberrant immune response in certain autoimmune diseases may not be attributable to self-antigen reactivity alone, but may be a synergistic effect, including a reaction to gut microbes. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease.
- Author
-
Bouziat, Romain, Hinterleitner, Reinhard, Brown, Judy J., Stencel-Baerenwald, Jennifer E., Ikizler, Mine, Mayassi, Toufic, Meisel, Marlies, Kim, Sangman M., Discepolo, Valentina, Pruijssers, Andrea J., Ernest, Jordan D., Iskarpatyoti, Jason A., Costes, Léa M. M., Lawrence, Ian, Palanski, Brad A., Varma, Mukund, Zurenski, Matthew A., Khomandiak, Solomiia, McAllister, Nicole, and Aravamudhan, Pavithra
- Subjects
- *
REOVIRUS diseases , *ANTIGENS , *CELIAC disease , *GLUTEN , *IMMUNOLOGY - Abstract
Viral infections have been proposed to elicit pathological processes leading to the initiation of T helper 1 (TH1) immunity against dietary gluten and celiac disease (CeD). To test this hypothesis and gain insights into mechanisms underlying virus-induced loss oftolerance to dietary antigens, we developed a viral infection model that makes use of two reovirus strains that infect the intestine but differ in their immunopathological outcomes. Reovirus is an avirulent pathogen that elicits protective immunity, but we discovered that it can nonetheless disrupt intestinal immune homeostasis at inductive andeffector sites of oral tolerance by suppressing peripheral regulatory T cell (pTreg) conversion and promoting TH1 immunity to dietary antigen. Initiation of TH1 immunity to dietary antigen was dependent on interferon regulatory factor 1 and dissociated fromsuppression of pTreg conversion, which was mediated by type-1 interferon. Last, our study in humans supports a role for infection with reovirus, a seemingly innocuous virus, in triggering the development of CeD. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. Innate and Adaptive Humoral Responses Coat Distinct Commensal Bacteria with Immunoglobulin A.
- Author
-
Bunker, Jeffrey J., Flynn, Theodore M., Koval, Jason C., Shaw, Dustin G., Meisel, Marlies, McDonald, Benjamin D., Ishizuka, Isabel E., Dent, Alexander L., Wilson, Patrick C., Jabri, Bana, Antonopoulos, Dionysios A., and Bendelac, Albert
- Subjects
- *
NATURAL immunity , *HUMORAL immunity , *IMMUNOGLOBULIN A , *HUMAN microbiota , *MUCOUS membranes , *CYTOMETRY - Abstract
Summary Immunoglobulin A (IgA) is prominently secreted at mucosal surfaces and coats a fraction of the intestinal microbiota. However, the commensal bacteria bound by IgA are poorly characterized and the type of humoral immunity they elicit remains elusive. We used bacterial flow cytometry coupled with 16S rRNA gene sequencing (IgA-Seq) in murine models of immunodeficiency to identify IgA-bound bacteria and elucidate mechanisms of commensal IgA targeting. We found that residence in the small intestine, rather than bacterial identity, dictated induction of specific IgA. Most commensals elicited strong T-independent (TI) responses that originated from the orphan B1b lineage and from B2 cells, but excluded natural antibacterial B1a specificities. Atypical commensals including segmented filamentous bacteria and Mucispirillum evaded TI responses but elicited T-dependent IgA. These data demonstrate exquisite targeting of distinct commensal bacteria by multiple layers of humoral immunity and reveal a specialized function of the B1b lineage in TI mucosal IgA responses. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
12. Well-trained, healthy triathletes experience no adverse health risks regarding oxidative stress and DNA damage by participating in an ultra-endurance event
- Author
-
Wagner, Karl-Heinz, Reichhold, Stefanie, Hölzl, Christine, Knasmüller, Siegfried, Nics, Lukas, Meisel, Marlies, and Neubauer, Oliver
- Subjects
- *
TRIATHLON , *OXIDATIVE stress , *DNA damage , *ULTRAENDURANCE sports , *PHYSICAL activity , *MACROMOLECULES , *VITAMIN E , *ANTIOXIDANTS - Abstract
Abstract: Also physical exercise in general is accepted to be protective, acute and strenuous exercise has been shown to induce oxidative stress. Enhanced formation of free radicals leads to oxidation of macromolecules and to DNA damage. On the other hand ultra-endurance events which require strenuous exercise are very popular and the number of participants is continuously increasing worldwide. Since only few data exists on Ironman triathletes, who are prototypes of ultra-endurance athletes, this study was aimed at assessing the risk of oxidative stress and DNA damage after finishing a triathlon and to predict a possible health risk. Blood samples of 42 male athletes were taken 2 days before, within 20min after the race, 1, 5 and 19 days post-race. Oxidative stress marker increased only moderately after the race and returned to baseline after 5 days. Marker of DNA damage measured by the SCGE assay with and without restriction enzymes as well as by the sister chromatid exchange assay did either show no change or deceased within the first day after the race. Due to intake during the race and the release by the cells plasma concentrations of vitamin C and α-tocopherol increased after the event and returned to baseline 1 day after. This study indicates that despite a temporary increase in some oxidative stress markers, there is no persistent oxidative stress and no DNA damage in response to an Ironman triathlon in trained athletes, mainly due to an appropriate antioxidant intake and general protective alterations in the antioxidant defence system. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
13. Natural polyreactive IgA antibodies coat the intestinal microbiota.
- Author
-
Bunker, Jeffrey J., Erickson, Steven A., Flynn, Theodore M., Henry, Carole, Koval, Jason C., Meisel, Marlies, Jabri, Bana, Antonopoulos, Dionysios A., Wilson, Patrick C., and Bendelac, Albert
- Subjects
- *
IMMUNOGLOBULIN A , *MONOCLONAL antibodies , *ENTEROBACTERIACEAE , *INTESTINES , *PLASMA cells - Abstract
The article analyzes the role of immunoglobulin A (IgA), the most abundant mammalian antibody isotype, in containing the resident commensal microbiota in the intestines. IgA is particularly prevalent at barrier surfaces and offers protection against enteric pathogens. Cloning of monoclonal antibodies (mAbs) from single murine IgA plasma cells is done to study the specificity of homeostatic IgA.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.